Leukemia, Myelodysplasia, Transplantation

News

Ibrutinib trial stopped early

Credit: Steven Harbour The phase 3 RESONATE study has been stopped early due to positive results in patients receiving ibrutinib. In this trial...

News

Ponatinib back on the market

Ariad Pharmaceuticals, Inc., has begun shipping the drug to Biologics, Inc., its exclusive specialty pharmacy.

News

Group discovers how drugs fight APL

Credit: The Armed Forces Institute of Pathology Results of a new study appear to explain how retinoic acid and arsenic trioxide work against...

News

Genetic events drive ALL subtype

a patient with ALL Investigators have identified the genetic events leading to leukemic transformation in ETV6-RUNX1 acute lymphoblastic leukemia...

Pages